Summit Therapeutics (NASDAQ:SMMT) Trading 2% Higher – Still a Buy?

Summit Therapeutics Inc. (NASDAQ:SMMT – Get Free Report)’s share price traded up 2% during trading on Friday . The company traded as high as $19.15 and last traded at $18.99. 428,440 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 3,736,956 shares. The stock had previously closed at […]

Leave a Reply

Your email address will not be published.

Previous post Allstate (NYSE:ALL) Price Target Cut to $216.00
Next post Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 2.1% – Time to Buy?